Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > :-)

<< Previous

Bullboard Posts

Next >>

Comment by Actuarialon Jul 15, 2021 4:47pm

128 Views

Post# 33553969

RE:RE:RE:RE:RE:RE:RE:RE:RE::-)

bad, or great, depends on time frame. short term, bad; long term, great. it depends on when you bought the stock and when you sell it. Also, it depends on your personal financial situation. If you need the fund to buy food, it will be very different from someone have a lot of cash. You and wounded see it bad at the moment, simply because you don't have the time options.